2019 -2024 Industry Representative to the US FDA Oncologic Drugs Advisory Committee (ODAC) @
2011 -2023 Oncology Global Regulatory Strategy Portfolio Lead @
2009 -2011 Vice President: Medicine Development @ Onyx Pharmaceuticals (acquired Proteolix)(acquired by Amgen)
2008 -2009 Vice President: Regulatory Affairs and Quality Assurance @ Proteolix (acquired by Onyx Pharmaceutricals)
2006 -2008 Board Member @ Kosan Bioscience Europe LTD
2006 -2008 Vice President: Drug Development, Pharmacovigilance and Regulatory Affairs @
1997 -2006 Group Director: Global Regulatory Strategy and US FDA Liason @
1985 -1997 Section Head, Toxicology, Human Safety and Regulatory Affairs @
Albert Kraus Education
University of Michigan
PhD (Biochemical Toxicology/ Cellular Chemistry)
1981-1985
Hamilton College
AB (Biology, Economics)
1977-1981
Albert Kraus Summary
Albert Kraus, based in Guilford, CT, US, is currently a Entrepreneur in Residence at Yale University. Albert Kraus brings experience from previous roles at GDS Partners LLC, NDA Group AB, FDA and Pfizer. Albert Kraus holds a 1981 - 1985 PhD in Biochemical Toxicology/ Cellular Chemistry @ University of Michigan. Albert Kraus has 1 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.